Abstract
Background
Stage IV colorectal cancer patients with unresectable metastasis who undergo elective primary tumour resection experience heterogeneous post-operative survival. We aimed to develop a scoring model for predicting post-operative survival using pre-operative variables to identify patients who are least likely to experience extended survival following the procedure.
Methods
Survival data were collected from stage IV colorectal cancer patients who had undergone elective primary tumour resection between January 1999 and December 2007. Coefficients of significant covariates from the multivariate Cox regression model were used to compute individual survival scores to classify patients into three prognostic groups. A survival function was derived for each group via Kaplan-Meier estimation. Internal validation was performed.
Results
Advanced age (hazard ratio, HR 1.43 (1.16–1.78)); poorly differentiated tumour (HR 2.72 (1.49–5.04)); metastasis to liver (HR 1.76 (1.33–2.33)), lung (HR 1.37 (1.10–1.71)) and bone (HR 2.08 ((1.16–3.71)); carcinomatosis (HR 1.68 (1.30–2.16)); hypoalbuminaemia (HR 1.30 (1.04–1.61) and elevated carcinoembryonic antigen levels (HR 1.89 (1.49–2.39)) significantly shorten post-operative survival. The scoring model separated patients into three prognostic groups with distinct median survival lengths of 4.8, 12.4 and 18.6 months (p < 0.0001). Internal validation revealed a concordance probability estimate of 0.65 and a time-dependent area under receiver operating curve of 0.75 at 6 months. Temporal split-sample validation implied good local generalizability to future patient populations (p < 0.0001).
Conclusion
Predicting survival following elective primary tumour resection using pre-operative variables has been demonstrated with the scoring model developed. Model-based survival prognostication can support clinical decisions on elective primary tumour resection eligibility.
Similar content being viewed by others
References
Siegel R, DeSantis C, Jemal A (2014) Colorectal cancer statistics, 2014. Ca-Cancer J Clin 64(2):104–117. doi:10.3322/Caac.21220
Ministry Of Health Singapore (2014) Disease Burden https://www.moh.gov.sg/content/moh_web/home/statistics/Health_Facts_Singapore/Disease_Burden.html Accessed 31 Oct 2014
Cook AD, Single R, McCahill LE (2005) Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 12(8):637–645. doi:10.1245/ASO.2005.06.012
Kim MS, Chung M, Ahn JB, Kim CW, Cho MS, Shin SJ, Baek SJ, Hur H, Min BS, Baik SH, Kim NK (2014) Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis. J Surg Oncol 110(2):214–221. doi:10.1002/jso.23607
Makela J, Haukipuro K, Laitinen S, Kairaluoma MI (1990) Palliative operations for colorectal cancer. Dis Colon Rectum 33(10):846–850
Law WL, Chu KW (2006) Outcomes of resection of stage IV rectal cancer with mesorectal excision. J Surg Oncol 93(7):523–528. doi:10.1002/jso.20506
Costi R, Leonardi F, Zanoni D, Violi V, Roncoroni L (2014) Palliative care and end-stage colorectal cancer management: the surgeon meets the oncologist. World J Gastroenterol : WJG 20(24):7602–7621. doi:10.3748/wjg.v20.i24.7602
Sineshaw HM, Robbins AS, Jemal A (2014) Disparities in survival improvement for metastatic colorectal cancer by race/ethnicity and age in the United States. Cancer Causes Control : CCC 25(4):419–423. doi:10.1007/s10552-014-0344-z
Kim YW, Kim IY (2013) The role of surgery for asymptomatic primary tumors in unresectable stage IV colorectal cancer. Ann Coloproctol 29(2):44–54. doi:10.3393/ac.2013.29.2.44
Cirocchi R, Trastulli S, Abraha I, Vettoretto N, Boselli C, Montedori A, Parisi A, Noya G, Platell C (2012) Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cochrane Db Syst Rev (8). doi:10.1002/14651858.Cd008997.Pub2
Yun JA, Huh JW, Park YA, Cho YB, Yun SH, Kim HC, Lee WY, Chun HK (2014) The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer. Dis Colon Rectum 57(9):1049–1058. doi:10.1097/Dcr.0000000000000193
Rahbari NN, Lordick F, Fink C, Bork U, Stange A, Jager D, Luntz SP, Englert S, Rossion I, Koch M, Buchler MW, Kieser M, Weitz J, Grp ST (2012) Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS—a randomised controlled multicentre trial (ISRCTN30964555). BMC Cancer 12. doi:10.1186/1471-2407-12-142
Jorine TB, Linda M, Cornelis V, Ton D, Cornelis P, Johannes D, Miriam K (2014) The Cairo4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer: a randomized phase III study. Ann Oncol 25:94–94. doi:10.1093/annonc/mdu165.264
Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B (2005) Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 92(9):1155–1160. doi:10.1002/bjs.5060
Michel P, Roque I, Di Fiore F, Langlois S, Scotte M, Teniere P, Paillot B (2004) Colorectal cancer with non resectable synchronous metastases: should the primary tumor be resected? Gastroenterol Clin Biol 28(5):434–437. doi:10.1016/S0399-8320(04)94952-4
Seo GJ, Park JW, Yoo SB, Kim SY, Choi HS, Chang HJ, Shin A, Jeong SY, Kim DY, Oh JH (2010) Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage IV colorectal cancer. J Surg Oncol 102(1):94–99. doi:10.1002/Jso.21577
Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD (2003) Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 196(5):722–728. doi:10.1016/S1072-7515(03)00136-4
Tarantino I, Warschkow R, Worni M, Cerny T, Ulrich A, Schmied BM, Guller U (2014) Prognostic relevance of palliative primary tumor removal in 37,793 metastatic colorectal cancer patients: a population-based, propensity score-adjusted trend analysis. . doi:10.1097/SLA.0000000000000860
Altman DG, Lausen B, Sauerbrei W, Schumacher M (1994) Dangers of using “optimal” cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86(11):829–835
Royston P, Altman DG, Sauerbrei W (2006) Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 25(1):127–141. doi:10.1002/Sim.2331
Schmid M, Potapov S (2012) A comparison of estimators to evaluate the discriminatory power of time-to-event models. Stat Med 31(23):2588–2609. doi:10.1002/sim.5464
Gonen M, Heller G (2005) Concordance probability and discriminatory power in proportional hazards regression. Biometrika 92(4):965–970. doi:10.1093/biomet/92.4.965
Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56(2):337–344
Kobayashi H, Kotake K, Sugihara K (2013) Prognostic scoring system for stage IV colorectal cancer: is the AJCC sub-classification of stage IV colorectal cancer appropriate? Int J Clin Oncol 18(4):696–703. doi:10.1007/s10147-012-0433-5
Golan T, Urban D, Berger R, Lawrence YR (2013) Changing prognosis of metastatic colorectal adenocarcinoma: differential improvement by age and tumor location. Cancer 119(16):3084–3091. doi:10.1002/cncr.28143
Costi R, Di Mauro D, Veronesi L, Ardizzoni A, Salcuni P, Roncoroni L, Sarli L, Violi V (2011) Elective palliative resection of incurable stage IV colorectal cancer: who really benefits from it? Surg Today 41(2):222–229. doi:10.1007/s00595-009-4253-9
Gallinger S, Biagi JJ, Fletcher GG, Nhan C, Ruo L, McLeod RS (2013) Liver resection for colorectal cancer metastases. Curr Oncol 20(3):e255–265. doi:10.3747/co.20.1341
Liu SK, Church JM, Lavery IC, Fazio VW (1997) Operation in patients with incurable colon cancer—is it worthwhile? Dis Colon Rectum 40(1):11–14
Kuo LJ, Leu SY, Liu MC, Jian JJM, Cheng SH, Chen CM (2003) How aggressive should we be in patients with stage IV colorectal cancer? Dis Colon Rectum 46(12):1646–1652. doi:10.1097/01.Dcr.0000093624.29029.3a
Yun J, Park J, Huh J, Park Y, Cho Y, Yun S, Kim H, Lee W (2014) The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer. Dis Colon Rectum 57(5):E293–E294
Ionescu D, Tibrea C, Puia C (2013) Pre-operative hypoalbuminemia in colorectal cancer patients undergoing elective surgery—a major risk factor for postoperative outcome. Chirurgia 108(6):822–828
Hong RX, Lin QJ, Luo J, Dai Z, Wang WN (2013) Clinical features and prognosis in 104 colorectal cancer patients with bone metastases. Zhonghua Zhong Liu Za Zhi [Chinese J Oncol] 35(10):787–791
Santini D, Tampellini M, Vincenzi B, Ibrahim T, Ortega C, Virzi V, Silvestris N, Berardi R, Masini C, Calipari N, Ottaviani D, Catalano V, Badalamenti G, Giannicola R, Fabbri F, Venditti O, Fratto ME, Mazzara C, Latiano TP, Bertolini F, Petrelli F, Ottone A, Caroti C, Salvatore L, Falcone A, Giordani P, Addeo R, Aglietta M, Cascinu S, Barni S, Maiello E, Tonini G (2012) Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol 23(8):2072–2077. doi:10.1093/annonc/mdr572
Yoon YS, Kim CW, Lim SB, Yu CS, Kim SY, Kim TW, Kim MJ, Kim JC (2014) Palliative surgery in patients with unresectable colorectal liver metastases: a propensity score matching analysis. J Surg Oncol 109(3):239–244. doi:10.1002/Jso.23480
Gerds TA, Kattan MW, Schumacher M, Yu C (2013) Estimating a time-dependent concordance index for survival prediction models with covariate dependent censoring. Stat Med 32(13):2173–2184. doi:10.1002/sim.5681
Chew MH, Teo JY, Kabir T, Koh PK, Eu KW, Tang CL (2012) Stage IV colorectal cancers: an analysis of factors predicting outcome and survival in 728 cases. J Gastrointest Surg 16(3):603–612. doi:10.1007/s11605-011-1725-1
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Disclosure
The authors declare no conflict of interest.
Source of funding
Nil
Rights and permissions
About this article
Cite this article
Dorajoo, S.R., Tan, W.J.H., Koo, S.X. et al. A scoring model for predicting survival following primary tumour resection in stage IV colorectal cancer patients with unresectable metastasis. Int J Colorectal Dis 31, 235–245 (2016). https://doi.org/10.1007/s00384-015-2419-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-015-2419-z